We invite you to our new webinar series on 21 CFR Part 11 compliance and regulations for flow cytometry in drug discovery.
These webinars are structured to provide valuable insights and practical knowledge that can enhance your understanding and application of these topics.
Part 1 and 2 of this webinar series focus on 21 CFR Part 11 compliance, which is essential for ensuring the integrity and security of electronic records in the pharmaceutical and biotechnology industries. They will cover the key elements of the regulation, its history, and implementation. You will learn about the necessary steps your organization must take to fulfil the regulatory requirements through standard operating procedures (SOPs) and work instructions. This session aims to provide a comprehensive understanding of how to achieve and maintain compliance, ensuring processes meet high standards of quality and reliability.
The final webinar focuses on flow cytometry in drug discovery; various stages of drug discovery and the degree of regulation required at each stage will be explored. Insights into different types of assays used will be provided, and the challenges and benefits of using flow cytometry in drug discovery, including its application in high-throughput screening.
